Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Cancer Journal (Sudbury, Mass.)|March 22, 2021
How Do We Meet the Challenge of Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors?Adam J Schoenfeld, Roisin E O'CearbhaillClinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2025
Can Longitudinal Biomarkers Guide Treatment Decisions? Time Will TellMark Y Jeng, Adam J SchoenfeldCancer Cell|April 15, 2020
Acquired Resistance to Immune Checkpoint InhibitorsAdam J Schoenfeld, Matthew D HellmannTransplantation and Cellular Therapy|March 15, 2025
The Clinical TIL Experience in Melanoma: Past, Present, FutureJames W Smithy, Adam J Schoenfeld, Allison Betof WarnerFuture Oncology (London, England)|January 19, 2024
Real-world safety of first-line immuno-oncology combination therapies for advanced non-small-cell lung cancerKeith A Betts, Sophie Gao, Saurabh Ray, et al.Cytotherapy|March 25, 2025
Entering a new era of tumor-infiltrating lymphocyte cell therapy innovationRodabe N Amaria, Krishna V Komanduri, Adam J Schoenfeld, et al.Future Oncology (London, England)|December 5, 2025
Real-world treatment patterns and attrition for non-driver mutation metastatic non-small cell lung cancer in the USAdam J Schoenfeld, Chen Hu, Ravi Rajaram, et al.Journal for Immunotherapy of Cancer|February 29, 2024
Expert consensus guidelines on management and best practices for tumor-infiltrating lymphocyte cell therapyAllison Betof Warner, Omid Hamid, Krishna Komanduri, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 3, 2024
Association of the time of day of chemoradiotherapy and durvalumab with tumor control in lung cancerMatthew T McMillan, Annemarie Shepherd, Alissa J Cooper, et al.Molecular Cancer Research : MCR|February 12, 2022
MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung CancerSudarshan R Iyer, Igor Odintsov, Adam J Schoenfeld, et al.Pageof 7